We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Oxford Nanopore Technologies plc (ONT) Ord GBP0.001

Sell:126.40p Buy:126.80p 0 Change: 0.60p (0.48%)
Market closed Prices as at close on 16 August 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:126.40p
Buy:126.80p
Change: 0.60p (0.48%)
Market closed Prices as at close on 16 August 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:126.40p
Buy:126.80p
Change: 0.60p (0.48%)
Market closed Prices as at close on 16 August 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Oxford Nanopore Technologies plc is engaged in the generation of molecular sensing technology based on nanopores. The Company has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. The Company’s segments include Life Science Research Tools, which offers products and services for research use, and COVID Testing, which provides products for SAR-Cov-2 testing. Its sequencing technology offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Its products include MinION, GridION, PromethION, Flongle and others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five MinION or Flongle Flow Cells. Flongle is an adapter for MinION or GridION that enables direct, real-time DNA sequencing, or cDNA sequencing on smaller, single-use flow cells.

Contact details

Address:
Oxford Science Park
Gosling Building, Edmund Halley Road
OXFORD
OX4 4DQ
United Kingdom
Telephone:
+ (0)
Website:
https://www.nanoporetech.com/

Important dates

Future events
Interim results 03 September 2024 03/09/24
Past events
Trading Announcement 24 July 2024 24/07/24
AGM 10 June 2024 10/06/24
Annual report 30 April 2024 30/04/24
Final results 06 March 2024 06/03/24
Trading Announcement 09 January 2024 09/01/24
Interim results 06 September 2023 06/09/23

General stock information

EPIC:
ONT
ISIN:
GB00BP6S8Z30
Market cap:
£1.19 billion
Shares in issue:
940.90 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Gurdial Sanghera
    Chief Executive Officer, Co-Founder, Executive Director
  • Nick Keher
    Chief Financial Officer, Executive Director
  • Jordan Herman
    Senior Vice President, General Counsel
  • Rich Compton
    Senior Vice President of Sales and Commercial Operations
  • Sarah Lapworth
    Senior Vice President, Global Human Resources
  • Rosemary Dokos
    Senior Vice President - Product & Programme Management
  • Zoe Mcdougall
    Senior Vice President - Strategic Communications and Corporate Affairs
  • John Schoellerman
    Senior Vice President - Corporate and Business Development
  • Emma Stanton
    Senior Vice President - Clinical and Head of Oxford Nanopore Diagnostics
  • Chris Brown
    Vice President - Strategic Programmes

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.